Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 4

Prophylactic Minimally Invasive Surfactant Evaluation

Endeavor Health · with Chiesi USA, Inc. · NCT06007547

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Any age listed · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 4
Target enrollment
200
US sites recruiting
1
Study start
January 1, 2024
Record last updated
August 7, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this study is to explore the question: Does prophylactic administration of exogenous surfactant in the delivery room, using a minimally-invasive technique, improve outcome in preterm infants 22-29 weeks' gestation compared to rescue treatment using the same technique?

Being studied: Poractant Alfa

Conditions: Respiratory Distress Syndrome, Newborn; Premature Birth

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Gestational age \<30 weeks
  • Antenatal consent from Parent

Exclusion Criteria

  • Congenital anomalies
  • Alternate cause of respiratory distress

Recruiting US locations

  • Northshore University Healthsystem

    Evanston, IL 60201

    Site contact: Matthew Derrick, mbbs · 847-570-2920 · mderrick@northshore.org

Study contacts (from the official record)

  • Matthew Derrick, MBBS · 8475702920 · mderrick@northshore.org
All healthy volunteers studies in Illinois →
Prophylactic Minimally Invasive Surfactant Evaluation (NCT06007547) | Bored Studies